Nephros Inc NEPH

$3.63 +0.10 (2.83%)

Valuation

Market cap
38,371,000
Revenue TTM
$18,790,000
Net income TTM
$1,190,000
PE ratio
32.00
Forward PE
23.47
Profit margin
6.33%
Debt to equity
0.00

Trading

Volume
39,000
Avg volume
34,490
Day's range
$3.53 – $3.70
Shares out
10,870,000
Stochastic %K
45%
Beta
1.64
Analysts
Sell
Price target
$6.25

Price

Company profile

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as we...

Show more

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
201 343 5202
Website
https://www.nephros.com
Address
380 Lackawanna Place, South Orange, United States

Latest news

No headlines yet.